Skip to main content

Table 2 The numbers of the case control subjects according to fatty acid quintiles and adjusted odds ratios in the study participants

From: Plasma fatty acids and the risk of metabolic syndrome in ethnic Chinese adults in Taiwan

  Q1 Q2    Q3    Q4    Q5    P, Trend
Saturated fat, % total fatty acids
Range < 38.0 38.0-40.1    40.1-42.5    42.5-45.7    > = 45.7    
Median 36.6 39.2    41.2    44.1    48.3    
Control 195 196    196    197    195    < .0001
Cases 127 168    221    201    281    
Odds ratio OR 95% CI OR 95% CI OR 95% CI OR 95% CI  
Model 1 1 1.31 0.97 1.78 1.75 1.30 2.34 1.57 1.16 2.11 2.22 1.66 2.97 < .0001
Model 2 1 1.05 0.67 1.64 1.48 0.97 2.28 1.20 0.78 1.84 1.94 1.27 2.96 0.002
Model 3 1 1.03 0.65 1.63 1.33 0.85 2.06 1.03 0.66 1.60 1.68 1.08 2.62 0.025
MUFA, % total fatty acids           
Range < 12.6 12.6-14.1    14.1-15.4    15.4-16.9    > = 16.9    
Median 11.5 13.5    14.7    16.2    18.2    
Control 195 196    197    196    195    < .0001
Cases 117 150    161    256    314    
Model 1 1 1.27 0.93 1.74 1.38 1.01 1.89 2.22 1.65 2.99 2.76 2.06 3.70 < .0001
Model 2 1 1.26 0.80 1.99 1.01 0.64 1.59 1.89 1.22 2.91 2.12 1.37 3.26 < .0001
Model 3 1 1.14 0.71 1.83 0.94 0.59 1.51 1.78 1.14 2.80 1.89 1.18 3.01 0.001
Transfat, % total fatty acids          
Range < 5.2 5.2-5.9    5.9-6.7    6.7-7.7    > = 7.7    
Median 4.6 5.5    6.3    7.2    8.7    
Control 195 197    194    197    196    < .0001
Cases 147 147    178    222    303    
Model 1 1 0.99 0.73 1.34 1.23 0.91 1.65 1.50 1.12 2.00 2.05 1.55 2.72 < .0001
Model 2 1 0.88 0.56 1.37 1.18 0.77 1.83 1.81 1.20 2.75 1.68 1.11 2.53 0.0003
Model 3 1 0.81 0.51 1.29 1.09 0.69 1.72 1.65 1.07 2.54 1.53 0.99 2.35 0.002
N-6 fatty acids, % total fatty acids       
Range < 28.7 28.7-31.1    31.1-33.3    33.3-35.8    > = 35.8    
Median 26.4 29.9    32.2    34.4    37.4    
Control 195 196    196    196    196    < .0001
Cases 363 225    181    159    70    
Model 1 1 0.62 0.48 0.80 0.50 0.38 0.65 0.43 0.33 0.57 0.19 0.14 0.27 < .0001
Model 2 1 0.83 0.57 1.21 0.65 0.44 0.96 0.55 0.38 0.82 0.31 0.20 0.49 < .0001
Model 3 1 0.84 0.57 1.24 0.69 0.46 1.04 0.64 0.42 0.97 0.36 0.22 0.59 < .0001
EPA, % total fatty acids          < .0001
Range < 0.28 0.28-0.38    0.38-0.52    0.52-0.76    > = 0.76    
Median 0.22 0.33    0.44    0.62    0.94    
Control 196 196    196    196    195    
Cases 299 186    185    186    142    
Model 1 1 0.62 0.47 0.81 0.60 0.46 0.79 0.60 0.45 0.78 0.46 0.34 0.61 < .0001
Model 2 1 0.61 0.41 0.92 0.51 0.34 0.76 0.67 0.45 0.99 0.51 0.33 0.77 0.013
Model 3 1 0.60 0.39 0.91 0.51 0.34 0.78 0.68 0.45 1.03 0.51 0.33 0.80 0.028
DHA, % total fatty acids             
Range < 1.97 1.97-2.45    2.45-2.89    2.89-3.56    > = 3.56    
Median 1.6 2.2    2.7    3.2    4.0    
Control 96 196    195    197    195    
Cases 281 256    167    161    133    
Model 1 1 0.89 0.69 1.16 0.58 0.44 0.77 0.55 0.42 0.73 0.45 0.34 0.60 < .0001
Model 2 1 0.97 0.66 1.43 0.68 0.45 1.02 0.54 0.36 0.82 0.58 0.38 0.89 0.001
Model 3 1 0.90 0.60 1.34 0.69 0.45 1.05 0.55 0.35 0.85 0.59 0.38 0.92 0.003
  1. Model 1: adjusted for age and gender
  2. Model 2: additional body mass index, smoking, drinking and exercise
  3. Model 3: additional LDL cholesterol, systolic and diastolic blood pressure, uric acid, fasting glucose levels and total fat amount in plasma
  4. Abbreviations see Table 1